Navigation Links
Mayo Clinic Proceedings: November highlights
Date:11/2/2010

The November issue of Mayo Clinic Proceedings includes three articles with leading research, highlighted below.

Khat Chewing Increases Risk of Stroke and Death in Patients With Acute Coronary Syndrome

ROCHESTER, Minn. -- Researchers found that people who chew khat and present with acute coronary syndrome had significantly higher rates of death, cardiogenic stroke, and stroke complications, despite having lower cardiovascular risk profiles.

"The leaves of khat, a leafy green shrub, are chewed habitually for euphoric and stimulating effects. The main ingredients, cathinone and cathine, are structurally related to amphetamine and ecstasy," says lead author Waleed Ali, M.D., from Hamad General Hospital in Doha, Qatar. An estimated 5 million to 10 million people worldwide chew khat, predominantly those living in the horn of Africa and the Arabian Peninsula, according to an editorial written by Farrah Mateen, from Johns Hopkins University in Baltimore, and Gregory Cascino, M.D., from the Department of Neurology at Mayo Clinic. They further state that Khat is illegal in the United States, and is not currently an accepted form of medical treatment.

Dr. Ali says, "Patients of Eastern African and Yemeni origins should be evaluated and counseled about khat chewing, even when living in Western countries."


Are Energy Beverages Safe to Drink When Exercising?

ROCHESTER, Minn. -- The resurgence of exercise has been accompanied by multiple supplements, sports drinks, and energy beverages that promise to enhance performance, muscle growth, and recovery. But the question remains: Are energy beverages safe?

"One can of an energy beverage during one session of exercise is safe for most healthy individuals," says John Higgins, M.D., lead author from The University of Texas Medical School in Houston. However, he states, "excess consumption and consumption with other caffeine-containing beverages or alcohol may lead to adverse effects and possibly death."

The United States is the world's largest consumer of energy beverages by volume, and consumption is primarily among people ages 11 to 35 years. The most common ingredient is caffeine, which ranges from 50 milligrams (mg) to 505 mg per 16-ounce serving.


Perspectives on Withdrawing Pacemakers and Implantable Cardioverter-Defibrillators at End of Life Vary Substantially

ROCHESTER, Minn. -- Mayo Clinic researchers found that the majority of medical professionals and patients feel implantable cardiac device (ICD) therapy should be withdrawn based on the patient's right to refuse continued life-sustaining therapy at the end of life.

"Almost one-third of medical professionals surveyed considered withdrawal of a pacemaker in a pacemaker-dependent patient as physician-assisted suicide or euthanasia, but only a very small percentage believed the same about an ICD," says Samuel Asirvatham, M.D., lead author and cardiologist, Mayo Clinic. The article noted that legal professionals tend to view all devices as similar and saw little difference between withdrawal of an ICD and withdrawal of a pacemaker.

"Education and discussion of managing devices at the end of life are important when making end-of-life decisions to better understand patients' perceptions and expectations," says Dr. Asirvatham.


'/>"/>

Contact: Rebecca Eisenman
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. The West Clinic Joins Cancer Clinics of Excellence (CCE)
2. Stethoscope App gives iPhone New Clinical Skills
3. Mayo Clinic responsible for $22 billion in economic impact, including $9.6 billion in Minnesota
4. Sunquest Introduces Integrated Clinical Environment Physician Portal Solution in US
5. Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials
6. Clinical trial underway: Miniature ultrasound device could revolutionize pain relief
7. Sunquest Completes System-Wide Implementation at Cleveland Clinic Hospital Laboratories
8. Michael J. Fox Foundation Awards $1.1 Million For Clinical Trial of Transdermal Nicotine as Disease-Modifying Treatment For Parkinsons
9. NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland
10. UCLA Health System Presents: How to Successfully Implement a Clinical Portal
11. International Merchant Advisors CEO Mel Roseman to Discuss New Medical Marijuana Clinics Live on CBS Radio Networks Big Biz Show February 22, 2010 at 1:40 pm PST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Yesterday, U.S. ... healthcare bill to repeal and replace the Affordable Care Act (ACA). Like the ... significant cuts to Medicaid, a public health insurance program for low-income children, pregnant ...
(Date:6/23/2017)... ... ... Everybody has their own personal preference when it comes to pornography. Some ... don't like it at all. FindaTopDoc took a look at what makes people attracted ... readers a taste of their deepest, darkest fantasies and has the ability to help ...
(Date:6/23/2017)... ... ... 21 Middle East and South Asia Leaders Selected as Eisenhower Fellows ... civil society in 11 countries across the Middle East and South Asia to embark ... of knowledge and ideas with the leading minds in their fields. , For ...
(Date:6/23/2017)... Francisco, CA (PRWEB) , ... June 23, 2017 , ... ... on 26th June, 2017 from 9 am to 3 pm to present to graduate ... The program is an original curriculum project led by The Health Improvement Service ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, ... area with access to asset protection and financial planning services, is teaming up ... improving the lives of children with cancer and other chronic diseases. , The ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Novavax, Inc., (Nasdaq: NVAX ) today announced that ... its RSV F protein recombinant nanoparticle vaccine candidate (RSV F ... in the journal Vaccine (the data ... conferences). The Company previously announced top line results ... RSV F Vaccine with the goal of protecting infants from ...
(Date:6/3/2017)... INDIANAPOLIS , June 3, 2017  Eli ... today announced that results from the Phase 3 ... kinase (CDK)4 & 6 inhibitor, in combination with ... treatment with fulvestrant alone in women with hormone-receptor-positive ... advanced breast cancer who have relapsed or progressed ...
(Date:5/30/2017)... , May 30, 2017 Hill-Rom Holdings, Inc. (NYSE: ... Annual Global Healthcare Conference on Tuesday, June 13, 2017, in ... Greisch , Hill-Rom,s president and chief executive officer, is scheduled ... live audio webcast can be accessed at http://ir.hill-rom.com/events.cfm . ... of the live event through September 13, 2017. ...
Breaking Medicine Technology: